0001127602-12-019748.txt : 20120611
0001127602-12-019748.hdr.sgml : 20120611
20120611144256
ACCESSION NUMBER: 0001127602-12-019748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120608
FILED AS OF DATE: 20120611
DATE AS OF CHANGE: 20120611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brykman Kurt Arthur
CENTRAL INDEX KEY: 0001303069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21244
FILM NUMBER: 12900211
MAIL ADDRESS:
STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION
STREET 2: 195 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0000799729
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 042776269
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7814879900
MAIL ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-06-08
0000799729
PAREXEL INTERNATIONAL CORP
PRXL
0001303069
Brykman Kurt Arthur
PAREXEL INTERNATIONAL CORPORATION
195 WEST STREET
WALTHAM
MA
02451
1
President, PACE and PCMS
Common Stock
2012-06-08
4
M
0
15800
12.55
A
104017
D
Common Stock
2012-06-08
4
S
0
26800
26.66
D
77217
D
Stock Option (Right to Buy)
12.55
2012-06-08
4
M
0
15800
0
D
2017-09-09
Common Stock
15800
15800
D
The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $26.49- $26.97. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.
/s/Douglas A. Batt, Attorney-in-fact
2012-06-11